How Does SLIT (Sublingual Immunotherapy) Work?

Allergy drops are one form of SLIT, but the terms are not perfectly interchangeable. SLIT, sublingual immunotherapy, is the broad category of immunotherapy taken under the tongue. It includes two main products: FDA-approved dissolving tablets that target a single allergen, such as grass, ragweed, or dust mite, and compounded liquid allergy drops that can be customized for multiple allergens and are used off-label in the United States. So all allergy drops are SLIT, but not all SLIT is delivered as drops. When people say allergy drops, they usually mean the customizable liquid form, while SLIT is the clinical umbrella term that also covers the tablets.

Both SLIT and allergy shots are immunotherapy that retrains the immune system, but they differ in delivery and risk profile. Allergy shots, or subcutaneous immunotherapy, are injected at a clinic on a regular schedule and use FDA-approved extracts with a long, strong evidence base. SLIT is taken at home under the tongue, with no needles and no routine office visits. Because SLIT is absorbed through the oral lining rather than injected, it carries a lower risk of systemic reactions than shots. That said, head-to-head superiority on effectiveness is not firmly established, and shots remain the more extensively studied option. The best choice depends on your allergens, lifestyle, and a clinician's assessment.

SLIT works gradually rather than immediately. Some people notice partial symptom improvement within the first few months or during their first allergy season on treatment, but the meaningful, durable benefit develops over a much longer period. Most clinicians recommend continuing SLIT for roughly three to five years to consolidate lasting tolerance, and stopping early raises the chance that benefits fade. The pace reflects the underlying biology: the immune system needs steady, repeated exposure over time to shift toward tolerating an allergen. Daily consistency therefore matters a great deal. Expecting fast relief like an antihistamine sets the wrong expectation; SLIT is a slow, cumulative treatment.

SLIT is generally well tolerated, and most side effects are mild and local, such as itching or tingling in the mouth, throat, or ears, or mild stomach upset, which often ease as the body adjusts. A 2024 meta-analysis found local reactions in roughly 40.8 percent of patients; fewer than 0.1 percent of patients in the program have systemic reactions, and anaphylaxis with SLIT is exceptionally rare. Still, no immunotherapy is completely without risk, and SLIT is not appropriate for everyone. People with uncontrolled asthma or eosinophilic esophagitis should not use it. A clinician should evaluate your history first and tell you what reactions to watch for and when to seek help.

No. SLIT works against the specific allergens it contains, and its evidence is strongest for inhaled environmental allergens, the pollens, dust mites, and animal dander behind allergic rhinitis and rhinoconjunctivitis. It is not a treatment for non-allergic conditions that can mimic hay fever, and it does little for symptoms not driven by the treated allergen. Food sublingual immunotherapy is investigational, with weaker evidence than for environmental allergies, so it is not a routine use. SLIT also only helps if the formula matches your true triggers, which is why testing comes first; treating an allergen you do not actually react to will not improve symptoms. A clinician confirms through testing and history whether your situation is one SLIT can realistically address.